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Abstract
Background Until recently there has been little data
available about long-term outcomes of laparoscopic rectal
cancer surgery. But new randomized controlled trials
regarding laparoscopic colorectal surgery have been pub-
lished. The aim of this study was to compare the short- and
long-term oncologic outcomes of laparoscopy and open
surgery for rectal cancer through a systematic review of the
literature and a meta-analysis of relevant RCTs.
Methods A systematic review of Medline, Embase and the
Cochrane library from January 1966 to October 2016 with
a subsequent meta-analysis was performed. Only random-
ized controlled trials with data on circumferential resection
margins were included. The primary outcome was the
status of circumferential resection margins. Secondary
outcomes included lymph node yield, distal resection
margins, disease-free and overall survival rates for 3 and
5 years and local recurrence rates.
Results Eleven studies were evaluated, involving a total of
2018 patients in the laparoscopic group and 1526 patients
in the open group. The presence of involved circumferen-
tial margins was reported in all studies. There were no
statistically significant differences in the number of posi-
tive circumferential margins between the laparoscopic
group and open group, RR 1.16, 95% CI 0.89–1.50 and no
significant differences in involvement of distal margins
(RR 1.13 95% CI 0.35–3.66), completeness of mesorectal
excision (RR 1.22, 95% CI 0.82–1.82) or number of har-
vested lymph nodes (mean difference = -0.01, 95% CI
-0.89 to 0.87). Disease-free survival rates at 3 and 5 years
were not different (p = 0.26 and p = 0.71 respectively),
and neither were overall survival rates (p = 0.19 and
p = 0.64 respectively), nor local recurrence rates (RR 0.88,
95% CI 0.63–1.23).
Conclusions Laparoscopic surgery for rectal cancer is
associated with similar short-term and long-term oncologic
outcomes compared to open surgery. The oncologic quality
of extracted specimens seems comparable regardless of the
approach used.
Keywords Laparoscopy  Total mesorectal excision 
Rectal cancer  Circumferential resection margin 
Survival  Local recurrence  Meta-analysis
Introduction
There has been a constant increase in the incidence of
colorectal cancer. Currently it is the most common gas-
trointestinal malignancy worldwide [1]. Approximately
one-third of all large bowel cancers are located in the
rectum [1]. So far, the primary treatment option for rectal
adenocarcinoma remains surgery, supported by neoadju-
vant and adjuvant therapy [2, 3].
Over the last two decades, a trend towards minimally
invasive surgery in the treatment of rectal cancer has been
observed [4]. In selected patients, laparoscopic surgery has
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been reported to achieve better short-term outcomes, which
include: lower postoperative morbidity, reduced intraop-
erative blood loss, less pain, faster recovery and better
quality of life [5–8]. Although there is much evidence
supporting laparoscopy in terms of perioperative parame-
ters, little is known of the influence of this surgical tech-
nique on long-term outcomes. It is generally accepted that,
from the oncologic perspective, disease-free survival is
considered a primary endpoint in the assessment of treat-
ment quality in rectal cancer. The most important surgical
factors related to long-term oncologic results are clear
resection margins and completeness of mesorectal exci-
sion. So far, several randomized trials comparing laparo-
scopic and open surgery have been conducted. However, in
most of them the oncologic outcomes are not set as primary
endpoints (thus creating potential bias related to under-
powering) or full resection details are not reported.
Moreover, the evidence on survival after open versus
laparoscopic surgery within a randomized controlled trial
(RCT) environment is sparse, with these results from high-
quality RCTs only recently published [9–11].
Our aim was to evaluate the effectiveness of laparo-
scopy and open surgery for rectal cancer by systematically
reviewing the available literature and conducting a meta-
analysis of RCTs comparing short-term and long-term
oncologic outcomes.
Materials and methods
Search strategy
In October 2016, a search was conducted by three teams,
with two researchers in each, of Medline, Embase and the
Cochrane Library, covering a period from January 1966 to
October 2016. The search had no language limitations, so
that the review would be as comprehensive as possible. A
full search strategy for strategy for OVID platform is
available in supplement 1. Reference lists of relevant
publications were assessed for additional studies. Further-
more, references from other systematic reviews or meta-
analyses on the subject were searched.
A study was included when it comprised adult patients,
rectal surgery for malignancy and reported on the circumfer-
ential resection margin (CRM) status. Only RCTs were
included. Studies were excluded if they were not full-text
papers, were not RCTs or did not report data on CRM. Studies
that fulfilled all the criteria were eligible for further evaluation.
All teams identified and selected citations from the
search independently. In case of doubt about inclusion, an
attempt was made to reach a consensus within the team. If
no consensus was possible, a decision was made by a third
member of the group outside that team. Data from included
studies were extracted independently by all teams. The
study quality and risk of bias was assessed using the
Cochrane Collaboration’s tool for assessing risk of bias.
Outcome measures
The primary outcome measures of this systematic review
were involved CRM status. Secondary outcome measures
were distal resection margin, completeness of mesorectal
excision, total number of harvested lymph nodes, 3-year
disease-free, 5-year disease-free and overall survival rate as
well as local recurrence rate. The quality of mesorectal
dissection was classified according to Nagtegaal et al. [12].
For the purpose of subsequent meta-analysis, similarly to
Nagtegaal’s original paper ‘complete’ and ‘nearly com-
plete’ mesorectal excisions were grouped together as
‘complete’ and were compared with ‘incomplete’
mesorectal excisions.
Statistical analysis
Analysis was performed using RevMan 5.3 (freeware from
the Cochrane Collaboration). Statistical heterogeneity and
inconsistency were measured using Cochran’s Q and I2,
respectively. Qualitative outcomes from individual studies
were analysed to assess individual and pooled risk ratios
(RR) with pertinent 95% confidence intervals (CI)
favouring the minimally invasive approach over open
surgery and by means of the Mantel–Haenszel fixed-effects
method in the presence of low or moderate statistical
inconsistency (I2 B 10%) and by means of a random-ef-
fects method (which better accommodates clinical and
statistical variations) in the case of high statistical incon-
sistency (I2[ 10%). For positive outcomes RR was cal-
culated for ‘non-event’ occurrence. When the study
included medians and interquartile ranges, we calculated
the mean ± standard deviation (SD) using a method pro-
posed by Hozo et al. [13]. Weighted mean differences
(WMD) with 95% CI are presented for quantitative vari-
ables using the inverse variance fixed-effects or random-
effects method. Statistical significance was observed with a
two-tailed 0.05 level for hypothesis and with 0.10 for
heterogeneity testing, while unadjusted p values were
reported accordingly. This study was performed according
to the Preferred Reporting Items for Systematic Reviews
and Meta-Analyses (PRISMA) guidelines.
Results
The initial reference search yielded 3446 articles. After
removing 1721 duplicates, 1725 articles were evaluated
through titles and abstracts. This produced 224 papers
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suitable for full-text review, of which 14 studies met the
eligibility criteria [9–11, 14–24]. There were 3 trials
(COLOR II, COREAN, CLASICC) in which results were
reported in more than one paper. Papers from the same trial
were analysed as one study, so that a total of 11 studies
were analysed; 2018 patients in the laparoscopic group and
1526 patients in the open group (Table 1). The literature
search and study selection is summarized in Fig. 1. Risk of
bias in the studies is assessed in Fig. 2. In general, the risk
of bias in the studies was low. Due to the nature of the
treatment, the blinding of participants and personnel was
impossible to perform. The outcome assessment was the
main source of bias as most of the studies did not clearly
define how and by whom it was performed. The paper with
the most potential for bias, Gong et al. [14], has been
included in the analysis as it had little impact on
heterogeneity.
Involved CRMs were reported in all 11 studies. None of
the analysed studies showed differences in CRM status
between the laparoscopic and open approach. Overall,
there were no statistically significant differences in the
number of positive CRMs between the laparoscopic group
(137/1847 (7.42%)) and the open group (83/1448 (5.73%)),
RR 1.16, 95% CI 0.89–1.50, p for effect = 0.27, p for
heterogeneity = 0.71, I2 = 0% (Fig. 3).
Data on involved distal margins were provided in 4/11
studies. None of the analysed studies showed differences in
positive distal margins between the laparoscopic and open
approach. The analysis revealed no significant differences
in distal margin positivity: 6/662 (0.91%) in the laparo-
scopic group versus 5/645 (0.78%) in the open group, RR
1.13 95% CI 0.35–3.66, p for effect = 0.84, p for hetero-
geneity = 0.59, I2 = 0% (Fig. 4).
The data on the completeness of mesorectal excision
were reported in 5/11 papers, involving 2339 patients. In 4
papers, the classification proposed by Nagtegaal et al. was
used. In the fifth paper, by Ng et al. [21], mesorectal
excision was described as complete or incomplete. In the 4
papers which used complete/nearly complete/incomplete
classification, complete mesorectal excision occurred in
1093/1308 (83.56%) of laparoscopic cases and 827/951
(86.96%) of open procedures. Nearly complete excision
was recorded in 161/1308 (12.30%) laparoscopic and
89/951 (9.36%) open procedures. Incomplete excision was
recorded in 54/1308 (4.13%) laparoscopic and 333/951
(3.47%) open procedures. The meta-analysis of all 5
studies reporting completeness of mesorectal excision
(complete was combined with nearly complete and com-
pared with incomplete as in Nagtegaal’s classification)
revealed no significant differences among the studies:
1290/1348 (95.69%) versus 953/991 (96.17%), RR 1.22,
95% CI 0.82–1.82, p for effect = 0.33, p for heterogene-
ity = 0.6, I2 = 0% (Fig. 5).
The number of harvested lymph nodes was reported in 9
studies. Kang et al. and van der Pas et al. reported open
procedures harvesting a greater number of lymph nodes,
whereas Lujan et al. reported the opposite [15, 17, 24]. The
remaining studies did not present statistically significant
data. Overall, the analysis revealed no statistically signifi-
cant differences among the studied groups, mean differ-
ence = -0.01, 95% CI -0.89 to 0.87, p for effect = 0.98,
p for heterogeneity = 0.001, I2 = 69% (Fig. 6).
The disease-free 3-year survival rate was reported in 5
papers, whereas an overall 3-year survival rate was repor-
ted in 6. There were no significant variations among the
groups [p = 0.26 and p = 0.18 (Figs. 7, 8)]. Five-year
survival and 5-year disease-free survival rates were each
reported in by 5 authors. There were no statistically
Fig. 1 PRISMA flowchart
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Fig. 2 Risk of bias summary
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significant differences in 5-year survival rate, p = 0.64. No
differences were found in terms of disease-free survival
either, p = 0.71 (Figs. 9, 10).
The local recurrence rate was reported in 8/11 studies. It
ranged from 2.35 to 9.88% in the laparoscopic group, and
4.47–11.11% in the open group. There were no statistically
significant variations among the studied groups, RR 0.88,
95% CI 0.63–1.23, p for effect = 0.45, p for heterogene-
ity = 0.79, I2 = 0% (Fig. 11).
Discussion
We found no difference in circumferential resection margin
involvement between laparoscopic and open surgery for
rectal cancer. Not difference was found in any other
oncological parameter, nor any difference in disease-free or
overall survival by 5 years.
The quality of included studies was mostly high and
very high. For obvious reasons, none of them blinded the
participants and only 5 studies blinded outcome assessors.
Fig. 3 Pooled estimates of involved circumferential resection margins comparing laparoscopy and open surgery. CI confidence interval, df
degrees of freedom, RR risk ratio
Fig. 4 Pooled estimates of involved distal margins comparing laparoscopy and open surgery. CI confidence interval, df degrees of freedom, RR
risk ratio
Fig. 5 Pooled estimates of completeness of mesorectal excision comparing laparoscopy and open surgery. CI confidence interval, df degrees of
freedom, RR risk ratio
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Although this may create potential bias, one should
remember that in surgical RCTs, blinding is either
impossible or at the very least, difficult. All analysed
studies included groups of patients undergoing laparo-
scopic resection, no robotic surgery was involved, although
there are currently several ongoing trials comparing
laparoscopic with robotic surgery registered at clinicaltri-
als.gov (NCT01736072 (ROLARR), NCT01130233,
NCT01985698 (RLOAPR), NCT01591798, NCT02673177
(TRVL), NCT02817126).
The involved CRM rate varied among studies between
1.2 and 15.5% in the laparoscopic group and 1.3–14.43%
in the open group. However, there was no overall differ-
ence between laparoscopic and open surgery and hetero-
geneity was low. Differences in CRM involvement
between studies may suggest that the quality of surgery
varied or (less probably) there were differences in patho-
logic assessment (there were no pre-operative differences
in T stage or use of neoadjuvant therapy between groups).
In our meta-analysis, the completeness of total mesorectal
excision was similar regardless of the technique used. In a
recent meta-analysis by Martı́nez-Pérez et al. [25], a dif-
ference in completeness of mesorectal excision was found
favouring open surgery. More studies were included for
Fig. 6 Pooled estimates of harvested lymph node yield comparing laparoscopy and open surgery. CI confidence interval, df degrees of freedom,
RR risk ratio
Fig. 7 Pooled estimates of 3-year disease-free survival rate comparing laparoscopy and open surgery. CI confidence interval, df degrees of
freedom, RR risk ratio
Fig. 8 Pooled estimates of 3-year overall survival rate comparing laparoscopy and open surgery. CI confidence interval, df degrees of freedom,
RR risk ratio
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data extraction in our review and we grouped together
‘complete’ and ‘nearly complete’ resections while Martı́-
nez-Pérez et al. compared ‘complete’ resections with a
group of flawed excisions (‘nearly complete’ combined
with ‘incomplete’). More data are needed to fully establish
whether there are differences in overall survival between
complete and nearly complete mesorectal excisions.
Abbas et al. [26] highlighted issues that might or might
not be relevant to short- and long-term oncologic outcomes
in laparoscopic rectal surgery. It was suggested that
laparoscopy may be inferior to the open approach due to
technical limitations leading to a so-called fulcrum/coning
effect during dissection, resulting in positive CRM or
incomplete mesorectal excision more often in lower rectal
cancers. However, our review we did not find differences
in CRM involvement, but only 1 study fully analysed the
outcomes in low rectal cancers [15], where statistically
different rates of CRM involvement were found in patients
Fig. 9 Pooled estimates of 5-year disease-free survival rate comparing laparoscopy and open surgery. CI confidence interval, df degrees of
freedom, RR risk ratio
Fig. 10 Pooled estimates of 5-year overall survival rate comparing laparoscopy and open surgery. CI confidence interval, df degrees of freedom,
RR risk ratio
Fig. 11 Pooled estimates of local recurrence rate comparing laparoscopy and open surgery. CI confidence interval, df degrees of freedom, RR
risk ratio
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with cancer of the lower third of the rectum and interest-
ingly, worse outcomes were observed in the open surgery
group (22% involved CRMs in the open group and 9% in
laparoscopic group). Certainly, a positive CRM strongly
correlates with the height of the tumour [15, 27, 28].
Because of high CRM involvement in low rectal cancers, a
novel bottom-up transanal total mesorectal excision has
been proposed and currently a multicentre RCT COLOR
III trial (NCT02736942) has started to fully assess the
oncologic benefits of this approach (estimated primary
completion date: May 2020) [29]. There were also differ-
ences in conversion rates among studies (1–34%), which
confirms the difficulty of the laparoscopic technique and
underlines issues with its standardization. High conversion
rates are associated with the learning curve and the surgical
unit’s experience as well as with tumour stage, which may
contribute to worse perioperative outcomes and may also
influence survival, although evidence is lacking to draw
firm conclusions [30–32].
The number of harvested lymph nodes was similar in the
laparoscopic and open group. However, lymph node yield
is dependent on many factors such as the tumour itself, the
patient, neoadjuvant radiochemotherapy, pathologic
assessment [33] and, last but not least, the surgeon [34].
Most importantly, operative technique has no impact on
long-term outcomes suggesting that, given the amount of
data available further RCTs comparing the laparoscopic
and open approach in terms of oncologic outcomes may not
be required.
The quality of data in this review has several limitations.
In practically all included studies long-term outcomes were
not set as a primary endpoint; therefore, most studies were
probably underpowered for this parameter. In addition, in
most of them involved CRM was used as a universal
marker of non-radical operation. However, there is agree-
ment that any involved margin is associated with poor
survival. Since distal margins (length and involvement)
were not reported in most studies, we were not able to fully
assess the R0 resection rate in the analysed groups.
According to Parmar et al. [35] in studies involving time to
event (survival-type) data, the most appropriate statistics to
use are the log hazard ratio and its variance. However, this
was not explicitly presented for included studies and we
had to compare data after 3 and 5 years post-surgery.
Surgeon experience and hospital volume in rectal surgery
are important factors influencing outcomes but in this
review surgeon experience was not analysed [36–38].
In conclusion, this systematic review with a meta-analysis
showed that laparoscopic surgery for rectal cancer is associ-
ated with similar short-term and long-term oncologic out-
comes compared to open surgery. The oncologic quality of
specimens seems comparable regardless of the approach used.
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